Interim guidance for healthcare providers and Zika virus laboratory diagnosis
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States.
Laboratory tests for Zika virus diagnostic
Laboratories should receive clinical and epidemiological information for establishing their investigation strategy, including date of onset of illness, travel history (date and locations), past flaviviral immunisation records and pregnancy status.
Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus
Kraemer, M.U.G., Reiner, R.C., Brady, O.J., Messina, J.P., Gilbert, M., Pigott, D.M., Yi, D., Johnson, K., Earl, L., Marczak, L.B., Shirude, S., Davis Weaver, N., Bisanzio, D., Perkins, T.A., Lai, S., Lu, X., Jones, P., Coelho, G.E., Carvalho, R.G., Van Bortel, W., Marsboom, C., Hendrickx, G., Schaffner, F., Moore, C.G., Nax, H.H., Bengtsson, L., Wetter, E., Tatem, A.J., Brownstein, J.S., Smith, D.L., Lambrechts, L., Cauchemez, S., Linard, C., Faria, N.R., Pybus, O.G., Scott, T.W., Liu, Q., Yu, H., Wint, G.R.W., Hay, S.I., Golding, N.